206 related articles for article (PubMed ID: 33960437)
21. Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.
Radkay LA; Chiosea SI; Seethala RR; Hodak SP; LeBeau SO; Yip L; McCoy KL; Carty SE; Schoedel KE; Nikiforova MN; Nikiforov YE; Ohori NP
Cancer Cytopathol; 2014 Dec; 122(12):873-82. PubMed ID: 25132659
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
[TBL] [Abstract][Full Text] [Related]
23. NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the HRASQ61R Mutation in Medullary Thyroid Cancer and May Have a Role in Triaging Genetic Testing for MEN2.
Reagh J; Bullock M; Andrici J; Turchini J; Sioson L; Clarkson A; Watson N; Sheen A; Lim G; Delbridge L; Sidhu S; Sywak M; Aniss A; Shepherd P; Ng D; Oei P; Field M; Learoyd D; Robinson BG; Clifton-Bligh RJ; Gill AJ
Am J Surg Pathol; 2017 Jan; 41(1):75-81. PubMed ID: 27635947
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma.
Massi D; Simi L; Sensi E; Baroni G; Xue G; Scatena C; Caldarella A; Pinzani P; Fontanini G; Carobbio A; Urso C; Mandalà M
Mod Pathol; 2015 Apr; 28(4):487-97. PubMed ID: 25341653
[TBL] [Abstract][Full Text] [Related]
25. Detection of RAS mutation by pyrosequencing in thyroid cytology samples.
Guerra A; Carrano M; Angrisani E; Puzziello A; Izzo G; Di Crescenzo V; Vatrella A; Vitale M
Int J Surg; 2014; 12 Suppl 1():S91-4. PubMed ID: 24866065
[TBL] [Abstract][Full Text] [Related]
26. A five-gene panel refines differential diagnosis of thyroid nodules.
Lu SY; Chen YC; Zhu CF; Chen J; Zhou QY; Zhang MM; Zhang QY; Lu M; Yang L; Wu J; Zhao SX; Song HD; Ye XP
J Clin Lab Anal; 2021 Sep; 35(9):e23920. PubMed ID: 34318534
[TBL] [Abstract][Full Text] [Related]
27. Clinical Utility of BRAF, NRAS, and TERT Promoter Mutation in Preoperative Thyroid Fine-Needle Aspiration Biopsy: A Diagnostic Study From Dharmais Cancer Hospital.
Perdana AB; Putri RI; Rachmawati R; Andinata B; Brahma B
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3267-3277. PubMed ID: 33247684
[TBL] [Abstract][Full Text] [Related]
28. Expression of HBME-1 and CD56 in follicular variant of papillary carcinoma in children: An immunohistochemical study and their diagnostic utility.
Skaria PE; Ahmed AA; Yin H; Nicol K; Reid KJ; Singh V
Pathol Res Pract; 2019 May; 215(5):880-884. PubMed ID: 30711197
[TBL] [Abstract][Full Text] [Related]
29. Confirmation of canine acanthomatous ameloblastoma using RAS Q61R immunohistochemical staining of formalin-fixed paraffin-embedded tissues.
Peralta S; Marcinczyk MM; Katt WP; Duhamel GE
Front Vet Sci; 2023; 10():1281022. PubMed ID: 37901104
[TBL] [Abstract][Full Text] [Related]
30. Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures.
Cracolici V; Mujacic I; Kadri S; Alikhan M; Niu N; Segal JP; Rosen LE; Sarne DH; Morgan A; Desouky S; Cipriani NA
Endocr Pathol; 2018 Mar; 29(1):9-14. PubMed ID: 28710706
[TBL] [Abstract][Full Text] [Related]
31. Preoperative detection of RAS mutation may guide extent of thyroidectomy.
Patel SG; Carty SE; McCoy KL; Ohori NP; LeBeau SO; Seethala RR; Nikiforova MN; Nikiforov YE; Yip L
Surgery; 2017 Jan; 161(1):168-175. PubMed ID: 27863786
[TBL] [Abstract][Full Text] [Related]
32. Constitutive Expression of NRAS with Q61R Driver Mutation Activates Processes of Epithelial-Mesenchymal Transition and Leads to Substantial Transcriptome Change of Nthy-ori 3-1 Thyroid Epithelial Cells.
Demin DE; Afanasyeva MA; Uvarova AN; Prokofjeva MM; Gorbachova AM; Ustiugova AS; Klepikova AV; Putlyaeva LV; Tatosyan KA; Belousov PV; Schwartz AM
Biochemistry (Mosc); 2019 Apr; 84(4):416-425. PubMed ID: 31228933
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules.
Clinkscales W; Ong A; Nguyen S; Harruff EE; Gillespie MB
Otolaryngol Head Neck Surg; 2017 Mar; 156(3):472-479. PubMed ID: 28116986
[TBL] [Abstract][Full Text] [Related]
34. Single Point Mutations in Pediatric Differentiated Thyroid Cancer.
Alzahrani AS; Murugan AK; Qasem E; Alswailem M; Al-Hindi H; Shi Y
Thyroid; 2017 Feb; 27(2):189-196. PubMed ID: 27824297
[TBL] [Abstract][Full Text] [Related]
35. Absence of BRAF, NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas.
Sadow PM; Heinrich MC; Corless CL; Fletcher JA; Nosé V
Endocr Pathol; 2010 Jun; 21(2):73-9. PubMed ID: 20012784
[TBL] [Abstract][Full Text] [Related]
36. TROP-2 immunohistochemistry: a highly accurate method in the differential diagnosis of papillary thyroid carcinoma.
Bychkov A; Sampatanukul P; Shuangshoti S; Keelawat S
Pathology; 2016 Aug; 48(5):425-33. PubMed ID: 27311870
[TBL] [Abstract][Full Text] [Related]
37. Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
Yang L; Dong D; Fang M; Zhu Y; Zang Y; Liu Z; Zhang H; Ying J; Zhao X; Tian J
Eur Radiol; 2018 May; 28(5):2058-2067. PubMed ID: 29335867
[TBL] [Abstract][Full Text] [Related]
38. Preoperative Role of RAS or BRAF K601E in the Guidance of Surgery for Indeterminate Thyroid Nodules.
Ravella L; Lopez J; Descotes F; Giai J; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Decaussin-Petrucci M
World J Surg; 2020 Jul; 44(7):2264-2271. PubMed ID: 32227276
[TBL] [Abstract][Full Text] [Related]
39. NRASQ61R Mutation-specific Immunohistochemistry is Highly Specific for Either NRASQ61R or KRASQ61R Mutation in Colorectal Carcinoma.
Turchini J; Andrici J; Sioson L; Clarkson A; Watson N; Toon CW; Shepherd P; Ng D; Dixon-McIver A; Oei P; Gill AJ
Appl Immunohistochem Mol Morphol; 2017 Aug; 25(7):475-480. PubMed ID: 26862952
[TBL] [Abstract][Full Text] [Related]
40. Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testing.
Lee SR; Jung CK; Kim TE; Bae JS; Jung SL; Choi YJ; Kang CS
Thyroid; 2013 Nov; 23(11):1416-22. PubMed ID: 23590130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
